Browse by Uncontrolled Keywords

Export as [feed] Atom [feed] RSS
Group by: Year | Authors/Creators | Item Type | Full Text
Jump to: 2011 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001
Number of items: 26.

2011

Bujkiewicz, S; Jones, HE; Lai, MC; Cooper, NJ; Hawkins, N; Squires, H; Abrams, KR; Spiegelhalter, DJ; Sutton, AJ; (2011) Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. Value in health, 14 (5). pp. 768-76. ISSN 1098-3015 DOI: https://doi.org/10.1016/j.jval.2010.12.002
[img]

2009

McKenna, C; Palmer, S; Rodgers, M; Chambers, D; Hawkins, N; Golder, S; van Hout, S; Pepper, C; Todd, D; Woolacott, N; (2009) Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom. Heart (British Cardiac Society), 95. pp. 542-549. ISSN 1355-6037 DOI: https://doi.org/10.1136/hrt.2008.147165 Full text not available from this repository.

Uzochukwu, BS; Onwujekwe, OE; Onoka, AC; Okoli, C; Uguru, NP; Chukwuogo, OI; (2009) Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health policy and planning, 24 (3). pp. 189-96. ISSN 0268-1080 DOI: https://doi.org/10.1093/heapol/czp006 Full text not available from this repository.

2008

Onwujekwe, O; Dike, N; Chukwuka, C; Uzochukwu, B; Onyedum, C; Onoka, C; Ichoku, H; (2008) Examining catastrophic costs and benefit incidence of subsidized antiretroviral treatment (ART) programme in south-east Nigeria. Health policy (Amsterdam, Netherlands), 90 (2-3). pp. 223-9. ISSN 0168-8510 DOI: https://doi.org/10.1016/j.healthpol.2008.10.006 Full text not available from this repository.

Ryan, M; Griffin, S; Chitah, B; Walker, AS; Mulenga, V; Kalolo, D; Hawkins, N; Merry, C; Barry, MG; Chintu, C; +2 more... Sculpher, MJ; Gibb, DM; (2008) The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. AIDS (London, England), 22. pp. 749-57. ISSN 0269-9370 DOI: https://doi.org/10.1097/QAD.0b013e3282f43519 Full text not available from this repository.

2007

Bravo Vergel, Y; Hawkins, NS; Claxton, K; Asseburg, C; Palmer, S; Woolacott, N; Bruce, IN; Sculpher, MJ; (2007) The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford, England), 46. pp. 1729-35. ISSN 1462-0324 DOI: https://doi.org/10.1093/rheumatology/kem221 Full text not available from this repository.

Ebri, A; Kuper, H; Wedner, S; (2007) Cost-effectiveness of cycloplegic agents: Results of a randomized controlled trial in Nigerian children. Investigative ophthalmology & visual science, 48 (3). pp. 1025-1031. ISSN 0146-0404 DOI: https://doi.org/10.1167/iovs.06-0604
[img]

2006

Barrett, A; Roques, T; Small, M; Smith, RD; (2006) How much will Herceptin really cost? BMJ, 333 (7578). pp. 1118-20. ISSN 1468-5833 DOI: https://doi.org/10.1136/bmj.39008.624051.BE
[img]

Sinanovic, E; Kumaranayake, L; (2006) Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa. Tropical medicine & international health, 11 (9). pp. 1466-1474. ISSN 1360-2276 DOI: https://doi.org/10.1111/j.1365-3156.2006.01686.x Full text not available from this repository.

2005

2004

Gutierrez, JP; Johns, B; Adam, T; Bertozzi, SM; Edejer, TT; Greener, R; Hankins, C; Evans, DB; (2004) Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? Lancet, 364 (9428). pp. 63-4. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(04)16590-2 Full text not available from this repository.

Jones, L; Griffin, S; Palmer, S; Main, C; Orton, V; Sculpher, M; Sudlow, C; Henderson, R; Hawkins, N; Riemsma, R; (2004) Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: A systematic review and economic evaluation. Health technology assessment (Winchester, England), 8 (38). iii-iv, 1-196. ISSN 1366-5278 http://researchonline.lshtm.ac.uk/id/eprint/2545583
[img]

Melegaro, A; Edmunds, WJ; (2004) Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales. Vaccine, 22 (31-32). pp. 4203-14. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2004.05.003 Full text not available from this repository.

2003

Grieve, R; Thompson, S; Normand, C; Suri, R; Bush, A; Wallis, C; (2003) A cost-effectiveness analysis of rhDNase in children with cystic fibrosis. International journal of technology assessment in health care, 19 (1). pp. 71-9. ISSN 0266-4623 DOI: https://doi.org/10.1017/S0266462303000072
[img]

Marks, D; Thorogood, M; Neil, HA; Wonderling, D; Humphries, SE; (2003) Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening. Journal of public health medicine, 25 (1). pp. 47-52. ISSN 0957-4832 DOI: https://doi.org/10.1093/pubmed/fdg010 Full text not available from this repository.

Pepin, J; Mabey, D; (2003) Sexually transmitted infections in Africa: single dose treatment is now affordable. Sexually transmitted infections, 79 (6). pp. 432-4. ISSN 1368-4973 DOI: https://doi.org/10.1136/sti.79.6.432 Full text not available from this repository.

2002

Boulle, A; Kenyon, C; Skordis, J; Wood, R; (2002) Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa. South African Medical Journal, 92 (10). pp. 811-7. ISSN 0256-9574 http://researchonline.lshtm.ac.uk/id/eprint/11150
[img]

Harries, AD; Hargreaves, NJ; Chimzizi, R; Salaniponi, FM; (2002) Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential. Bulletin of the World Health Organization, 80 (6). pp. 464-9. ISSN 0042-9686 http://researchonline.lshtm.ac.uk/id/eprint/8901
[img]

Schroeder, K; Ebrahim, S; Fahey, T; Montgomery, A; Peters, T; (2002) Daily regimen and compliance with treatment. All available evidence needs to be evaluated. BMJ, 324 (7334). p. 425. ISSN 1468-5833 DOI: https://doi.org/10.1136/bmj.324.7334.425
[img]

Suri, R; Grieve, R; Normand, C; Metcalfe, C; Thompson, S; Wallis, C; Bush, A; (2002) Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Thorax, 57 (10). pp. 841-6. ISSN 0040-6376 DOI: https://doi.org/10.1136/thorax.57.10.841 Full text not available from this repository.

2001

Feachem, R; (2001) HAART--the need for strategically focused investments. Bulletin of the World Health Organization, 79 (12). pp. 1152-3. ISSN 0042-9686 http://researchonline.lshtm.ac.uk/id/eprint/10958
[img]

Holloway, KA; Gautam, BR; Reeves, BC; (2001) The effects of different kinds of user fee on prescribing costs in rural Nepal. Health policy and planning, 16 (4). pp. 421-7. ISSN 0268-1080 http://researchonline.lshtm.ac.uk/id/eprint/17312 Full text not available from this repository.

Mason, J; Freemantle, N; Nazareth, I; Eccles, M; Haines, A; Drummond, M; (2001) When is it cost-effective to change the behavior of health professionals? JAMA, 286 (23). pp. 2988-2992. ISSN 0098-7484 DOI: https://doi.org/10.1001/jama.286.23.2988
[img]

This list was generated on Thu Mar 21 23:15:15 2019 GMT.